Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Franklin Liu

Showing results (31-40 of 39) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 39 results.
Plos One|September 17, 2013
Downstream signaling pathways in mouse adipose tissues following acute in vivo administration of fibroblast growth factor 21Eric S Muise, Sandra Souza, An Chi, et al.
Diabetes|March 1, 2018
Erratum. Engineering Glucose Responsiveness Into Insulin. Diabetes 2018;67:299-308Niels C Kaarsholm, Songnian Lin, Lin Yan, et al.
Diabetes|November 4, 2017
Engineering Glucose Responsiveness Into InsulinNiels C Kaarsholm, Songnian Lin, Lin Yan, et al.
Diabetes|July 16, 2009
Glucagon-like peptide 1/glucagon receptor dual agonism reverses obesity in miceAlessandro Pocai, Paul E Carrington, Jennifer R Adams, et al.
Urologic Oncology|June 26, 2024
Predictive factors for recurrence and outcomes in T1a renal cell carcinoma: Analysis of the INMARC (International Marker Consortium for Renal Cancer) databaseFranklin Liu, Luke Wang, Margaret F Meagher, et al.
World Journal of Urology|March 1, 2023
Partial or radical nephrectomy for complex renal mass: a comparative analysis of oncological outcomes and complications from the ROSULA (Robotic Surgery for Large Renal Mass) Collaborative GroupClara Cerrato, Devin Patel, Riccardo Autorino, et al.
Minerva Urology and Nephrology|August 2, 2023
Partial versus radical nephrectomy for complex renal mass: multicenter comparative analysis of functional outcomes (Rosula collaborative group)Clara Cerrato, Margaret F Meagher, Riccardo Autorino, et al.
Frontiers in Oncology|April 17, 2023
Proposal for a Two-Tier Re-classification of Stage IV/M1 domain of Renal Cell Carcinoma into M1 ("Oligometastatic") and M2 ("Polymetastatic") subdomains: Analysis of the Registry for Metastatic Renal Cell Carcinoma (REMARCC)Margaret F Meagher, Maria C Mir, Andrea Minervini, et al.
Science (New York, N.Y.)|July 15, 2017
Systemic pan-AMPK activator MK-8722 improves glucose homeostasis but induces cardiac hypertrophyRobert W Myers, Hong-Ping Guan, Juliann Ehrhart, et al.
Pageof 4

Showing results (31-40 of 39) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 39 results.
Plos One|September 17, 2013
Downstream signaling pathways in mouse adipose tissues following acute in vivo administration of fibroblast growth factor 21Eric S Muise, Sandra Souza, An Chi, et al.
Diabetes|March 1, 2018
Erratum. Engineering Glucose Responsiveness Into Insulin. Diabetes 2018;67:299-308Niels C Kaarsholm, Songnian Lin, Lin Yan, et al.
Diabetes|November 4, 2017
Engineering Glucose Responsiveness Into InsulinNiels C Kaarsholm, Songnian Lin, Lin Yan, et al.
Diabetes|July 16, 2009
Glucagon-like peptide 1/glucagon receptor dual agonism reverses obesity in miceAlessandro Pocai, Paul E Carrington, Jennifer R Adams, et al.
Urologic Oncology|June 26, 2024
Predictive factors for recurrence and outcomes in T1a renal cell carcinoma: Analysis of the INMARC (International Marker Consortium for Renal Cancer) databaseFranklin Liu, Luke Wang, Margaret F Meagher, et al.
World Journal of Urology|March 1, 2023
Partial or radical nephrectomy for complex renal mass: a comparative analysis of oncological outcomes and complications from the ROSULA (Robotic Surgery for Large Renal Mass) Collaborative GroupClara Cerrato, Devin Patel, Riccardo Autorino, et al.
Minerva Urology and Nephrology|August 2, 2023
Partial versus radical nephrectomy for complex renal mass: multicenter comparative analysis of functional outcomes (Rosula collaborative group)Clara Cerrato, Margaret F Meagher, Riccardo Autorino, et al.
Frontiers in Oncology|April 17, 2023
Proposal for a Two-Tier Re-classification of Stage IV/M1 domain of Renal Cell Carcinoma into M1 ("Oligometastatic") and M2 ("Polymetastatic") subdomains: Analysis of the Registry for Metastatic Renal Cell Carcinoma (REMARCC)Margaret F Meagher, Maria C Mir, Andrea Minervini, et al.
Science (New York, N.Y.)|July 15, 2017
Systemic pan-AMPK activator MK-8722 improves glucose homeostasis but induces cardiac hypertrophyRobert W Myers, Hong-Ping Guan, Juliann Ehrhart, et al.
Pageof 4